Redefining Treatment for Neurodevelopmental Disorders Redefining Treatment for Neurodevelopmental Disorders Corporate Overview Mark Davies October 2026 | ASX: NTI Executive Chairman 0 Forward-Looking Statements Forward-Looking Statements This presentation includes forward looking statements....
Corporate Presentation
Filed with ASX · · 20 pages · English
Release
Neurotech International Ltd. on 6ix
In the deck
Earlier from Neurotech International
- Becoming a substantial holder
- Change of Director's Interest Notice
- Annual Report (Typeset)
- Notice of Annual General Meeting/Proxy Form
- NTI Doses First Patient in Phase 3 Beyond Harmony ASD Study
Later from Neurotech International
- Ceasing to be a substantial holder
- Quarterly Activities/Appendix 4C Cash Flow Report
- Results of Meeting
Follow Neurotech International into a list and get an email when it puts out news.
Follow Neurotech International